Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, Y. R.
Right arrow Articles by Kim, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, Y. R.
Right arrow Articles by Kim, H.
[Cancer Research 63, 2188-2193, May 1, 2003]
© 2003 American Association for Cancer Research


Molecular Biology and Genetics

Overexpression of High Mobility Group Box 1 in Gastrointestinal Stromal Tumors with KIT Mutation1

Yon Rak Choi2, Hyunki Kim2, Hyun Ju Kang2, Nam-Gyun Kim, Jung Jin Kim, Kang-Sik Park, Young-Ki Paik, Hyun Ok Kim and Hoguen Kim3

Department of Pathology [Y. R. C., Hy. K., H. J. K., N-G. K., J. J. K., Ho. K.], Brain Korea 21 Projects for Medical Sciences [Y. R. C., Hy. K., H. J. K.], Laboratory Medicine [H. O. K.], Yonsei Proteome Research Center [K-S. P., Y-K. P.], and Cancer Metastasis Research Center [N-G. K., Ho. K.], Yonsei University College of Medicine, 120-752 Seoul, Korea

Gain-of-function mutations of KIT are common genetic events in gastrointestinal stromal tumors (GISTs). To investigate the molecular characteristics of KIT mutations in GISTs, 20 GISTs (14 GISTs with KIT mutation and 6 GISTs without KIT mutation) were analyzed by two-dimensional electrophoresis and matrix-associated laser desorption ionization mass spectrophotometry-time of flight. Comparative analysis of the respective spot patterns on two-dimensional electrophoresis showed that HMGB1, an intranuclear protein that interacts with several transcription factors and plays a role in tumor metastasis after its secretion, was overexpressed in GISTs with KIT mutation. All of the 14 GISTs with KIT mutation, and only 2 of 6 GISTs without KIT mutation, revealed HMGB1 expression. Of the GISTs with KIT mutation, 12 (86%) showed strong expression of HMGB1, more than three times higher in intensity than the maximum observed in the 6 GISTs without KIT mutation by two-dimensional electrophoresis analysis. The overexpression of HMGB1 was further supported by Western blot analysis, and directly related to matrix metalloproteinase 2 overexpression. Our results indicate that the overexpression of HMGB1 is common in GISTs and is related to the KIT mutation, and that this may play a role in the tumorigenesis of GISTs because overexpressed HMGB1 could accelerate genes related to tumor growth and invasion.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. S. Li, J. C. Morales, A. Hwang, M. W. Wagner, and D. A. Boothman
DNA Mismatch Repair-dependent Activation of c-Abl/p73{alpha}/GADD45{alpha}-mediated Apoptosis
J. Biol. Chem., August 1, 2008; 283(31): 21394 - 21403.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. Lasota, B. Wasag, S. E. Steigen, J. Limon, and M. Miettinen
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors
J. Mol. Diagn., February 1, 2007; 9(1): 89 - 94.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K Volp, M-L Brezniceanu, S Bosser, T Brabletz, T Kirchner, D Gottel, S Joos, and M Zornig
Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
Gut, February 1, 2006; 55(2): 234 - 242.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Semino, G. Angelini, A. Poggi, and A. Rubartelli
NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1
Blood, July 15, 2005; 106(2): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
F. Tribl, M. Gerlach, K. Marcus, E. Asan, T. Tatschner, T. Arzberger, H. E. Meyer, G. Bringmann, and P. Riederer
"Subcellular Proteomics" of Neuromelanin Granules Isolated from the Human Brain
Mol. Cell. Proteomics, July 1, 2005; 4(7): 945 - 957.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. R. Raspollini, G. Amunni, A. Villanucci, G. Baroni, A. Taddei, and G. L. Taddei
c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study
Ann. Onc., April 1, 2004; 15(4): 594 - 597.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.